How do I switch from Ozempic to Mounjaro? Take your last Ozempic dose as usual, wait about 7 days until your next injection day, then start Mounjaro at 2.5 mg once a week, whatever dose of Ozempic you were on. There is no dose conversion, and the label climbs by 2.5 mg at a time, at least 4 weeks apart, up to 15 mg.
- In SURMOUNT-5, the only head-to-head trial in obesity, tirzepatide took off 20.2% of body weight in 72 weeks against 13.7% for semaglutide (Aronne et al., 2025).
- The Mounjaro label starts everyone at 2.5 mg once weekly for 4 weeks, then 5 mg, then up in 2.5 mg steps at least 4 weeks apart, to 15 mg a week.
- Semaglutide has a half-life of about 1 week, so the first Mounjaro dose lands on your next weekly injection day, about 7 days after your last Ozempic dose.
- In SURMOUNT-1, nausea affected 24.6% to 33.3% of people on tirzepatide, diarrhoea 18.7% to 23.0%, vomiting 8.3% to 12.2% and constipation 11.7% to 17.1%, mostly during dose increases (Jastreboff et al., 2022).
- Worked example: an 85 kg woman eating at maintenance instead of her 1,936 calorie target for the first 4 weeks would take in about 14,000 extra calories, roughly 1.8 kg of fat not lost.
Introduction
Ozempic is semaglutide for type 2 diabetes (Wegovy for weight management); Mounjaro is tirzepatide for type 2 diabetes (Zepbound for weight management). This post uses the names most people search for. Our guide to
GLP-1 weight loss explained covers how these medicines work.
People usually switch because weight loss has stalled, blood sugar is not where they want it, or the cost and coverage of one drug works out better. The switch follows a simple pattern, and the mistakes are the same every time: starting too high, overlapping the two drugs, or expecting full strength from the first injection. This post walks through what the labels and the trials say. It is general information, not medical advice.
Why People Switch: What the Head-to-Head Trial Found
Until 2025, every comparison was indirect. SURMOUNT-5 changed that. It randomised 751 adults with obesity and without diabetes to the maximum tolerated dose of tirzepatide (10 or 15 mg) or semaglutide (1.7 or 2.4 mg) for 72 weeks: tirzepatide took off 20.2% of body weight against 13.7% for semaglutide, and waist size fell by 18.4 cm against 13.0 cm (Aronne et al., 2025). It was open-label and funded by Eli Lilly, which makes tirzepatide, so read it as strong evidence rather than the final word.
SURPASS-2 randomised 1,878 adults with type 2 diabetes on metformin to tirzepatide or semaglutide 1 mg for 40 weeks. On the highest tirzepatide dose, A1c fell by 2.30% and weight by 11.2 kg, against 1.86% and 5.7 kg on semaglutide, and 51% on tirzepatide 15 mg reached an A1c below 5.7% (Frias et al., 2021). Note that semaglutide 1 mg was the highest diabetes dose licensed at the time, while the weight-management dose is 2.4 mg. A switch still means starting over at the bottom of a new dose ladder, with months of increases and a fresh round of side effects.
The Two Drugs Are Not the Same Dose
The most important fact about switching is that there is no conversion between these two drugs. Semaglutide copies one gut hormone, GLP-1. Tirzepatide copies GLP-1 and a second gut hormone, GIP, at the same time. Their milligrams do not line up: a 2.4 mg dose of semaglutide does not equal any particular dose of tirzepatide, and no trial has ever published a conversion chart.
Because there is no conversion, the label starts everyone at the bottom: 2.5 mg injected under the skin once a week, for starting treatment rather than blood sugar control. After 4 weeks it rises to 5 mg, then by 2.5 mg at a time, after at least 4 weeks on each dose, up to a maximum of 15 mg a week in adults. The ladder moves slowly to reduce gut side effects, and the label makes no exception for people coming from semaglutide.
The Switch in Four Steps
Step 1: Take your last Ozempic dose as usual
Take your final semaglutide dose on your normal day, at your normal dose. Do not skip it or take a smaller dose to taper. Keeping your routine makes the timing easy.
Step 2: Wait about 7 days
Take your first Mounjaro dose on the day your next Ozempic dose would have been due, about 7 days after your last semaglutide dose. There is no long washout, and you do not need one. Semaglutide has a half-life of about 1 week, and the label says it stays in circulation for about 5 weeks after the last dose. Because you are starting tirzepatide at its lowest dose, the small amount of semaglutide still in your system is not a dose-stacking concern. Never take both drugs in the same week.
Step 3: Start Mounjaro at 2.5 mg once a week
The first dose is 2.5 mg once weekly, whatever your Ozempic dose was.
| Your last Ozempic dose |
First Mounjaro dose |
How the switch feels |
| 0.25 or 0.5 mg weekly |
2.5 mg weekly |
The smallest change |
| 1 mg weekly |
2.5 mg weekly |
A step down for the first few weeks |
| 2 mg weekly |
2.5 mg weekly |
The biggest step down; appetite can come back for a few weeks |
Step 4: Climb the ladder, 2.5 mg at a time
Stay on 2.5 mg for the first 4 weeks, then move to 5 mg, then up by 2.5 mg at a time, at least 4 weeks apart, up to 15 mg. Your prescriber may hold you longer on a dose. If you miss a dose, the label says take it within 4 days; after that, skip it and take the next dose on your usual day.
| Weeks |
Mounjaro dose |
| Weeks 1 to 4 |
2.5 mg once weekly |
| Weeks 5 to 8 |
5 mg once weekly |
| Weeks 9 to 12 |
7.5 mg once weekly |
| Weeks 13 to 16 |
10 mg once weekly |
| Weeks 17 to 20 |
12.5 mg once weekly |
| Week 21 onwards |
15 mg once weekly (maximum) |
The Disagreement: 2.5 mg or 5 mg to Start?
The guides disagree here. The label starts everyone at 2.5 mg, with no exception for people already on a GLP-1. Some clinics, though, report starting at 5 mg for people who were already on a GLP-1 and tolerating it well. That 5 mg start is clinic practice, not the label, and no trial has compared the two starting doses in switchers.
Starting at 2.5 mg is slower and gentler, but it means more weeks at a dose that does little for appetite or blood sugar. Starting at 5 mg gets you to an effective dose faster, but it raises the chance of nausea and vomiting in the first weeks. This is a decision for your prescriber, who knows your dose history and your tolerance.
The First Month, Week by Week
Week 0: Your last Ozempic dose
Nothing changes. Take your dose as usual, and sort out the new prescription, any prior authorisation, and the cost first, so there is no gap. Mounjaro is approved for type 2 diabetes, while Zepbound is the same tirzepatide approved for weight management, so check which brand your prescription is for.
Week 1: Your first Mounjaro dose
Take 2.5 mg on your next injection day, 7 days after your last Ozempic dose. The day of the week stays the same. Some people feel nothing different; others notice nausea returning within a day or two.
Weeks 2 to 4: Stay on 2.5 mg
The label keeps you on 2.5 mg for the first 4 weeks, and this stretch catches people out. The dose is a starting dose, not a treatment dose, so appetite often comes back and the scale may stall. That is the drug working as labelled, not the switch failing. The food habits you built on Ozempic matter most in these weeks: small protein-first meals, steady fluids, and the eating pattern in our guide to
what to eat on Ozempic.
Week 5: Step up to 5 mg
After 4 weeks, the label moves you to 5 mg, and appetite usually tightens again, though the gut side effects may return with it. From here the pattern repeats: 4 weeks on a dose, a step up, a few days of adjustment, then settling.
Why Side Effects Can Come Back
Side effects can come back even if you tolerated Ozempic well. Tolerating one drug does not guarantee tolerating the other, because the dose ladder starts over. In SURMOUNT-1, the gut side effects of tirzepatide were common and dose related: nausea affected 24.6% of people on 5 mg, 33.3% on 10 mg and 31.0% on 15 mg; diarrhoea 18.7%, 21.2% and 23.0%; vomiting 8.3%, 10.7% and 12.2%; and constipation 16.8%, 17.1% and 11.7% (Jastreboff et al., 2022). Most were mild to moderate, and they clustered during dose escalation.
In STEP 1, semaglutide caused nausea in 44.2%, diarrhoea in 31.5%, vomiting in 24.8% and constipation in 23.4% (Wilding et al., 2021). The numbers are not directly comparable across trials, but gut side effects return with each dose increase. If you sailed through Ozempic at a stable dose, you may still feel sick again at 5 mg or 7.5 mg of Mounjaro, and that usually eases. The eating rules that helped on Ozempic help again: small meals, protein first, low fat on bad days, fluids through the day.
What Happens to Appetite and Weight During the Switch
The first month is often a pause, not a loss. At 2.5 mg, tirzepatide is a starting dose, and appetite commonly returns while you are on it. Take the person our other guides use: a woman aged 40, 165 cm, 85 kg, moderately active, burning about 2,436 calories a day, with a weight loss target of about 1,936 calories a day. Her protein number comes from our
protein intake calculator: 85 kg times 1.2 g/kg equals 102 grams a day.
If her appetite returns during the first 4 weeks and she eats at maintenance, about 2,436 calories a day instead of her 1,936 calorie target, that is 500 extra calories a day. Over 28 days that is 14,000 calories, which is about 1.8 kg of fat not lost, at the standard figure of about 7,700 calories per kilogram of body fat. Work out your own numbers with our
calories calculator before the switch.
That pause is temporary. As the dose climbs, appetite usually tightens again: in SURMOUNT-5, tirzepatide reached 20.2% weight loss by 72 weeks, against 13.7% on semaglutide (Aronne et al., 2025). The switch pays off over months, not weeks. Our guide to
how to break a weight loss plateau covers how to tell a real stall from a pause.
When to Talk to Your Prescriber
If you have type 2 diabetes and take insulin or a sulfonylurea, contact your prescriber before the switch, because the new drug changes blood sugar and those doses may need adjusting. Contact them during the switch if you cannot keep food or fluids down, if vomiting or diarrhoea lasts more than a day, if you notice signs of dehydration such as very little urine, dizziness or a racing heart, or if you have severe stomach pain. Seek urgent care for severe symptoms. Never change your own dose or stop either medicine without discussing it with your prescriber.
Frequently Asked Questions
How do I switch from Ozempic to Mounjaro?
Take your last Ozempic dose as usual, wait about 7 days until your next injection day, then start Mounjaro at 2.5 mg once a week. Climb by 2.5 mg at a time, at least 4 weeks apart, up to 15 mg.
How long should I wait between Ozempic and Mounjaro?
About 7 days: take your first Mounjaro dose on the day your next Ozempic dose would have been due. There is no long washout, and you should never take both drugs in the same week.
What dose of Mounjaro do I start on after Ozempic?
The label starts everyone at 2.5 mg once weekly, whatever Ozempic dose you were on, because there is no dose conversion. Some clinics start at 5 mg for people already on a GLP-1, but that is clinic practice, not the label.
Will side effects come back when I switch?
They can, even if you tolerated Ozempic well. In SURMOUNT-1, nausea affected about 25% to 33% of people on tirzepatide, mostly during dose increases. The side effects usually ease as you stay on each dose.
Will I gain weight during the switch?
Weight often stalls in the first month, because 2.5 mg is a starting dose and appetite can return. Eating at maintenance for 4 weeks instead of your target costs about 1.8 kg of fat not lost for the worked example, but it is a pause, not a reversal.
—
Sources
- Aronne LJ, Horn DB, le Roux CW, et al. N Engl J Med. 2025;393(1):26-36. SURMOUNT-5: 751 adults, tirzepatide minus 20.2% vs semaglutide minus 13.7% at 72 weeks. https://pubmed.ncbi.nlm.nih.gov/40353578/
- Frias JP, Davies MJ, Rosenstock J, et al. N Engl J Med. 2021;385:503-515. SURPASS-2: 1,878 adults with type 2 diabetes, tirzepatide 15 mg A1c minus 2.30% and weight minus 11.2 kg vs semaglutide 1 mg minus 1.86% and minus 5.7 kg. https://pubmed.ncbi.nlm.nih.gov/34170647/
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. N Engl J Med. 2022;387(3):205-216. SURMOUNT-1: 2,539 adults, minus 15.0%, minus 19.5%, minus 20.9% vs minus 3.1% placebo at 72 weeks; nausea 24.6 to 33.3%; diarrhoea 18.7 to 23.0%; vomiting 8.3 to 12.2%; constipation 11.7 to 17.1%. https://pubmed.ncbi.nlm.nih.gov/35658024/
- Wilding JPH, Batterham RL, Calanna S, et al. N Engl J Med. 2021;384(11):989-1002. STEP 1: 1,961 adults, semaglutide 2.4 mg, minus 14.9% vs minus 2.4% placebo at 68 weeks; nausea 44.2%, vomiting 24.8%, diarrhoea 31.5%, constipation 23.4%. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Eli Lilly and Company. Mounjaro (tirzepatide) prescribing information. Starting dose 2.5 mg once weekly; 5 mg after 4 weeks; then 2.5 mg increments after at least 4 weeks; maximum 15 mg in adults; missed dose within 4 days. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=0818426a-53eb-4db7-9609-bbae1e7a3964
- Ozempic (semaglutide) prescribing information. Elimination half-life about 1 week; present in circulation for about 5 weeks after the last dose. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
- Weight Insider. GLP-1 weight loss explained, what to eat on Ozempic, how to break a weight loss plateau, protein intake calculator, and calories calculator.
Last updated: 22 November 2026
Medical Disclaimer
This article is general information only. It is not medical advice, and it is not a substitute for advice from a qualified health professional. It does not tell you what dose of any medicine to take, or whether to start, stop, switch or taper any medicine. Talk to your doctor or prescriber before changing your medicine, especially if you have diabetes, kidney disease, or any other health condition, or if you are pregnant or breastfeeding.